PBG Deaminase, WB

What is PBG Deaminase?

PBG Deaminase (also called porphobilinogen deaminase, uroporphyrinogen I synthase, or hydroxymethylbilane synthase) is a key enzyme in the heme biosynthesis pathway — the process by which your body makes heme, a vital component of hemoglobin, myoglobin, and other important proteins.

Heme is essential for transporting oxygen in the blood and for many cellular processes, including energy production and detoxification. PBG Deaminase is the third enzyme in this pathway and plays a critical role in converting porphobilinogen (PBG) into hydroxymethylbilane, which eventually becomes heme.

---

Why is PBG Deaminase Measured in Whole Blood?

The PBG Deaminase, WB test measures the activity of the PBG Deaminase enzyme in red blood cells. Measuring enzyme activity in whole blood helps detect certain inherited disorders of heme metabolism, especially acute intermittent porphyria (AIP).

---

Clinical Relevance: Acute Intermittent Porphyria (AIP)

AIP is a rare genetic metabolic disorder caused by a partial deficiency of PBG Deaminase. People with AIP cannot properly break down porphyrin precursors, leading to a buildup of toxic substances like ALA (aminolevulinic acid) and PBG in the body. This can cause serious and sometimes life-threatening symptoms, particularly affecting the nervous system.

Symptoms of AIP May Include:

• Sudden, severe abdominal pain (without clear cause)

• Muscle weakness or paralysis

• Anxiety, confusion, or hallucinations

• Seizures

• Rapid heart rate or high blood pressure

• Dark-colored urine (due to excess porphyrins)

Attacks are often triggered by medications, fasting, stress, infection, or hormonal changes. Identifying low PBG Deaminase activity helps confirm a diagnosis, especially when paired with elevated levels of ALA and PBG in the urine during an attack.

---

What Does an Abnormal Result Mean?

Low PBG Deaminase Activity

• Strongly suggests AIP, particularly when symptoms and other porphyrin-related tests align.

• May also indicate a silent genetic carrier (someone with a mutation who may never have symptoms but can pass it on to offspring).

• Important for family screening—AIP is inherited in an autosomal dominant pattern, meaning only one copy of the gene mutation is needed to be at risk.

Normal or High Activity

• Makes AIP unlikely, especially if other tests (urinary ALA, PBG) are also normal.

• Other types of porphyria or conditions with similar symptoms may need to be ruled out.

---

Who Should Be Tested?

Testing PBG Deaminase activity is typically recommended for individuals who:

• Have symptoms suggestive of AIP

• Have family members with AIP

• Have had positive urine porphyrin screening tests

• Are undergoing differential diagnosis for unexplained abdominal pain and neurological symptoms

---

Important Notes About the Test

• Sample type: Whole blood, typically collected in EDTA tubes.

• The enzyme is heat-sensitive, so the sample must be kept cold and processed quickly to avoid degradation.

• Results should be interpreted in the context of clinical symptoms, family history, and other porphyrin-related tests.

---

Follow-Up and Management

If PBG Deaminase activity is low and AIP is diagnosed:

• Your healthcare provider may recommend genetic testing to identify specific mutations.

• You may need to avoid triggering medications, manage stress, and maintain a balanced diet to prevent acute attacks.

• In some cases, heme arginate or glucose infusions are used to treat attacks.

---

Summary

PBG Deaminase, WB is a specialized enzyme test used primarily to diagnose acute intermittent porphyria (AIP) — a rare but serious disorder of heme synthesis. Low enzyme activity confirms the presence of a genetic defect affecting heme metabolism, often requiring lifestyle adjustments and medical supervision to prevent dangerous metabolic crises.